Back to top
more

Intuitive Surgical (ISRG)

(Delayed Data from NSDQ)

$506.34 USD

506.34
1,041,901

+2.50 (0.50%)

Updated Nov 1, 2024 03:59 PM ET

After-Market: $506.75 +0.41 (0.08%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value C Growth B Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 32% (79 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Intuitive Surgical (ISRG) Beats on Q4 Earnings & Revenues

Intuitive Surgical (ISRG) gains from revenue growth in Instrument & Accessories plus Services and Systems segments in Q4.

    Abbott (ABT) Tops Q4 Earnings and Revenues, Issues Guidance

    Abbott (ABT) posts promising Q4 results on strong growth in all lines and expansion in emerging markets.

      Accuray (ARAY) Q2 Loss Narrower Than Estimates, Revenues Top

      Radixact System and major software overhaul drive Accuray (ARAY) in Q2.

        AngioDynamics (ANGO) Banks on Buyouts, Debt Level High

        AngioDynamics (ANGO) continues to expand its business on the back of acquisitions and strategic alliances.

          Walgreens Boots' Retail Pharmacy Strong, Competition Rife

          Walgreens Boots (WBA) rides high on continued prescription growth and strength in the Retail Pharmacy USA division.

            PetMed (PETS) Q3 Earnings Top Estimates, Reorder Sales Solid

            The upside in third-quarter fiscal 2018 sales at PetMed (PETS) is a result of the significant increase in new orders and reorder sales.

              ResMed (RMD) Beats Q2 Earnings & Sales on Growth in All Lines

              ResMed (RMD) beats earnings and sales in Q2 on solid contributions from domestic and international businesses.

                Abiomed Hits New 52-Week High: 3 Factors Driving the Stock

                Abiomed (ABMD) recently reported strong preliminary third-quarter fiscal 2018 results.

                  Zacks.com highlights: Caterpillar, Crocs, Pioneer Natural Resources, Legg Mason and Intuitive Surgical

                  Zacks.com highlights: Caterpillar, Crocs, Pioneer Natural Resources, Legg Mason and Intuitive Surgical

                    Becton, Dickinson Completes Enrollment in Lutonix DCB Trial

                    Becton, Dickinson's (BDX) focus in the Balloon-Angioplasty space is expected to lend the company a competitive edge in the niche MedTech markets.

                      Medtronic's FDA Nod for Riptide Aspiration System Boosts RTG

                      Medtronic (MDT) makes efforts to boost RTG business.

                        Becton, Dickinson Hits a 52-Week High: What's Driving It?

                        Becton, Dickinson (BDX) rides on favorable regulatory developments and strategic acquisitions.

                          5 Top Stocks Powered by Beat Potential This Earnings Season

                          Bet on five stocks that are likely to outdo earnings estimates.

                            Medtronic (MDT) Wins FDA Nod for New Clinician Programmer

                            Medtronic's (MDT) latest FDA nod likely to boost Pain Therapies division.

                              5 Reasons Why You Should Offload Wright Medical Stock Now

                              Foreign currency fluctuations and pricing pressure continue to be major headwinds for Wright Medical Group (WMGI).

                                5 Reasons Why McKesson Deserves a Place in Your Portfolio

                                McKesson (MCK) continues to pursue deals, divestitures and acquisitions to drive growth. The company's impressive performance in 2017 accounts for its potential to sustain the momentum.

                                  Will Intuitive Surgical (ISRG) Disappoint in Q4 Earnings?

                                  Intuitive Surgical (ISRG) is expected to witness growth across da Vinci Surgical and Service segments. Instruments and accessories revenues are also expected to increase year over year.

                                    Medtronic's ITB Therapy Superior to CMM for PSS Reduction

                                    Medtronic (MDT) consistently tries efforts to boost Pain Therapies division, part of the Restorative Therapies Group.

                                      Myriad Genetics Fortifies Molecular Diagnostics With FDA Nod

                                      Myriad Genetics (MYGN) has been leaving no stone unturned to boost the uptake of BRACAnalysis CDx test and strengthen the Molecular Diagnostics portfolio.

                                        QIAGEN Partners DiaSorin, Boosts Molecular Diagnostics Arm

                                        QIAGEN (QGEN) continues to adopt initiatives to strengthen Molecular Diagnostics business.

                                          Express Scripts 90-Day Analysis of Opioid Management Positive

                                          Express Scripts (ESRX) addresses the national opioid epidemic by reducing excessive and improper opioid use.

                                            Henry Schein (HSIC) Buys ABASE, Expands in Animal Health

                                            Henry Schein (HSIC) forges ahead with deals to strengthen the Global Animal Health business.

                                              Baxter (BAX) Launches Arisure Closed System Transfer Device

                                              Baxter's (BAX) Arisure Closed System reduces exposure risk of healthcare professionals to needles. Also, the latest development promotes safe handling of hazardous drugs.

                                                Abbott's (ABT) Diabetes Care Unit Strong on FreeStyle Libre

                                                Abbott (ABT) forges ahead with initiatives to boost diabetes care. The latest CMS recognition will widen customer base for FreeStyle Libre glucose monitoring system.

                                                  Integra LifeSciences Estimates Strong Revenue Figures for Q4

                                                  Integra LifeSciences (IART) sees strong organic growth in the company's Specialty Surgical Solutions as well as Orthopedics and Tissue Technologies businesses.